Marco Basset

11PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 02, 2024
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

Claudia Bellofiore, Pietro Benvenuti, Roberto Mina

|May 16, 2023
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets.

Alice Nevone, Francesca Lattarulo, Monica Russo

|Jun 30, 2022
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.

Marco Basset, Paolo Milani, Andrea Foli

|May 24, 2022
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.

Alice Nevone, Maria Girelli, Silvia Mangiacavalli

|Aug 03, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-up.

Marco Basset, Christoph R Kimmich, Nicholas Schreck

|Sep 03, 2020
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy.

Paolo Milani, Marco Basset, Mario Nuvolone

Pageof 2

Frequent Collaborators

6 joint publications

Giampaolo Merlini

6 joint publications

Giovanni Palladini

4 joint publications

Claudia Bellofiore

4 joint publications

Mario Nuvolone